Zur Startseite gehen
0,00 €*
Cover: 9783030315023 | Statistical Methods in Biomarker and Early Clinical Development | Buch
Dekorationsartikel gehören nicht zum Leistungsumfang.
Statistical Methods in Biomarker and Early Clinical Development
Buch von Cheng Su (u. a.)
Sprache: Englisch

149,79 €*

inkl. MwSt.

Versandkostenfrei per Post / DHL

Aktuell nicht verfügbar

Kategorien:
Beschreibung
This contributed volume offers a much-needed overview of the statistical methods in early clinical drug and biomarker development. Chapters are written by expert statisticians with extensive experience in the pharmaceutical industry and regulatory agencies. Because of this, the data presented is often accompanied by real world case studies, which will help make examples more tangible for readers. The many applications of statistics in drug development are covered in detail, making this volume a must-have reference.
Biomarker development and early clinical development are the two critical areas on which the book focuses. By having the two sections of the book dedicated to each of these topics, readers will have a more complete understanding of how applying statistical methods to early drug development can help identify the right drug for the right patient at the right dose. Also presented are exciting applications of machine learning and statistical modeling, along with innovative methods and state-of-the-art advances, making this a timely and practical resource.
This volume is ideal for statisticians, researchers, and professionals interested in pharmaceutical research and development. Readers should be familiar with the fundamentals of statistics and clinical trials.
This contributed volume offers a much-needed overview of the statistical methods in early clinical drug and biomarker development. Chapters are written by expert statisticians with extensive experience in the pharmaceutical industry and regulatory agencies. Because of this, the data presented is often accompanied by real world case studies, which will help make examples more tangible for readers. The many applications of statistics in drug development are covered in detail, making this volume a must-have reference.
Biomarker development and early clinical development are the two critical areas on which the book focuses. By having the two sections of the book dedicated to each of these topics, readers will have a more complete understanding of how applying statistical methods to early drug development can help identify the right drug for the right patient at the right dose. Also presented are exciting applications of machine learning and statistical modeling, along with innovative methods and state-of-the-art advances, making this a timely and practical resource.
This volume is ideal for statisticians, researchers, and professionals interested in pharmaceutical research and development. Readers should be familiar with the fundamentals of statistics and clinical trials.
Über den Autor
¿Liang Fang is an Executive Director and Head of Biostatistics in MyoKardia Inc. His research interests include statistical applications in drug development, precision medicine, and digital health.
Cheng Su is an Executive Director of Data Science & Analytics at BioMarin, Inc. His research interests include statistical applications and tool development in drug discovery, biomarkers, clinical trials design, risk based monitoring, mobile health and big data.
Zusammenfassung

Presents statistical methods in early clinical drug and biomarker development in one convenient volume

Includes chapters written by experts in the pharmaceutical industry

Emphasizes practical applications by highlighting real-world examples, state-of-the-art developments, and innovative methods

Inhaltsverzeichnis
Predictive Subgroup/Biomarker Identification and Machine Learning Methods.- Characterize and Dichotomize a Continuous Biomarker.- Surrogate Biomarkers.- Innovative Designs for Biomarker Guided Trials.- Statistical Considerations in the Development of Companion Diagnostic Device.- Biomarker Assay Development, Qualification and Validation.- Validation of Genomic Based Assay.- Clinical Application of Molecular Features in Therapeutic Selection and Drug Development.- Big data, real-world data, and machine learning.- Design and Analysis of Clinical Pharmacology Studies.- Statistical Considerations in Proof of Concept Studies.- Safety in Early Phase Studies.- Statistical Evaluation of QT/QTc Interval Prolongation.- Phase II Dose Finding.- Pharmacometrics.
Details
Erscheinungsjahr: 2019
Fachbereich: Wahrscheinlichkeitstheorie
Genre: Mathematik, Medizin, Naturwissenschaften, Technik
Rubrik: Naturwissenschaften & Technik
Medium: Buch
Inhalt: xii
348 S.
23 s/w Illustr.
31 farbige Illustr.
348 p. 54 illus.
31 illus. in color.
ISBN-13: 9783030315023
ISBN-10: 3030315029
Sprache: Englisch
Ausstattung / Beilage: HC runder Rücken kaschiert
Einband: Gebunden
Redaktion: Su, Cheng
Fang, Liang
Herausgeber: Liang Fang/Cheng Su
Auflage: 1st ed. 2019
Hersteller: Springer International Publishing
Maße: 241 x 160 x 25 mm
Von/Mit: Cheng Su (u. a.)
Erscheinungsdatum: 27.12.2019
Gewicht: 0,705 kg
Artikel-ID: 117261922
Über den Autor
¿Liang Fang is an Executive Director and Head of Biostatistics in MyoKardia Inc. His research interests include statistical applications in drug development, precision medicine, and digital health.
Cheng Su is an Executive Director of Data Science & Analytics at BioMarin, Inc. His research interests include statistical applications and tool development in drug discovery, biomarkers, clinical trials design, risk based monitoring, mobile health and big data.
Zusammenfassung

Presents statistical methods in early clinical drug and biomarker development in one convenient volume

Includes chapters written by experts in the pharmaceutical industry

Emphasizes practical applications by highlighting real-world examples, state-of-the-art developments, and innovative methods

Inhaltsverzeichnis
Predictive Subgroup/Biomarker Identification and Machine Learning Methods.- Characterize and Dichotomize a Continuous Biomarker.- Surrogate Biomarkers.- Innovative Designs for Biomarker Guided Trials.- Statistical Considerations in the Development of Companion Diagnostic Device.- Biomarker Assay Development, Qualification and Validation.- Validation of Genomic Based Assay.- Clinical Application of Molecular Features in Therapeutic Selection and Drug Development.- Big data, real-world data, and machine learning.- Design and Analysis of Clinical Pharmacology Studies.- Statistical Considerations in Proof of Concept Studies.- Safety in Early Phase Studies.- Statistical Evaluation of QT/QTc Interval Prolongation.- Phase II Dose Finding.- Pharmacometrics.
Details
Erscheinungsjahr: 2019
Fachbereich: Wahrscheinlichkeitstheorie
Genre: Mathematik, Medizin, Naturwissenschaften, Technik
Rubrik: Naturwissenschaften & Technik
Medium: Buch
Inhalt: xii
348 S.
23 s/w Illustr.
31 farbige Illustr.
348 p. 54 illus.
31 illus. in color.
ISBN-13: 9783030315023
ISBN-10: 3030315029
Sprache: Englisch
Ausstattung / Beilage: HC runder Rücken kaschiert
Einband: Gebunden
Redaktion: Su, Cheng
Fang, Liang
Herausgeber: Liang Fang/Cheng Su
Auflage: 1st ed. 2019
Hersteller: Springer International Publishing
Maße: 241 x 160 x 25 mm
Von/Mit: Cheng Su (u. a.)
Erscheinungsdatum: 27.12.2019
Gewicht: 0,705 kg
Artikel-ID: 117261922
Warnhinweis

Ähnliche Produkte

Diese Website verwendet Cookies, um eine bestmögliche Erfahrung bieten zu können. Mehr Informationen ...